Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Kabir ZD, Martínez-Rivera A, Rajadhyaksha AM.

Neurotherapeutics. 2017 Jul;14(3):588-613. doi: 10.1007/s13311-017-0532-0. Review.

PMID:
28497380
2.

A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

Cipriani A, Saunders K, Attenburrow MJ, Stefaniak J, Panchal P, Stockton S, Lane TA, Tunbridge EM, Geddes JR, Harrison PJ.

Mol Psychiatry. 2016 Oct;21(10):1324-32. doi: 10.1038/mp.2016.86. Epub 2016 May 31. Review.

3.

Comparative study of electrocardiographic changes in patients of acute mania receiving verapamil or lithium carbonate.

Singh M, Kaur S, Sehgal VK.

J Clin Diagn Res. 2014 Dec;8(12):HC08-11. doi: 10.7860/JCDR/2014/9920.5268. Epub 2014 Dec 5.

4.

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.

Tamayo JM, Zarate CA Jr, Vieta E, Vázquez G, Tohen M.

Int J Neuropsychopharmacol. 2010 Jul;13(6):813-32. doi: 10.1017/S1461145709991246. Epub 2010 Feb 4. Review.

5.

Neuropsychiatric consequences of cardiovascular medications.

Huffman JC, Stern TA.

Dialogues Clin Neurosci. 2007;9(1):29-45. Review.

6.

Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.

Ulrich ML, Rotzinger S, Asghar SJ, Jurasz P, Tanay VA, Dunn SM, Radomski M, Greenshaw A, Silverstone PH.

J Psychiatry Neurosci. 2003 Mar;28(2):115-25.

7.

Supplemental Content

Support Center